CIPHARM
Generieke medicijnen, tabletten, siropen en farmaceutische formuleringen.
CIPHARM produceert generieke medicijnen, tabletten, siropen en farmaceutische formuleringen vanuit haar activiteiten in Abidjan. Het bedrijf levert aan apotheekkanalen, ziekenhuisinkopers, distributeurs in de gezondheidszorg of exportklanten op zijn beursgenoteerde primaire markten.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Abidjan, Côte d'Ivoire
- Founded
- 1988
- Website
- cipharm.ci
- Categories
- Medische en gezondheidszorgbenodigdheden, Supplementen & Welzijn
- Markets
- Ivoorkust, Senegal, Ghana, Kameroen
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- debarment-clear (green), checked 2026-08-05 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-08-05 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-05 Mail server of the company domain
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)